Sabitlenmiş Tweet

Abatacept treatment (anti-CD80/CD86) revealing a statistically significant mortality benefit for severe COVID patients is further proof of the T-mediated aspect of disease.
@fitterhappierAJ correct again, not just in science, but as revealed in the clinical data.
NIH@NIH
News: Immune modulator drugs improved survival for people hospitalized with COVID-19 dlvr.it/SRVp5j
English

















